nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acromegalic osteopathy
|
Mazziotti, G. |
|
2016 |
20 |
1 |
p. 63-69 |
artikel |
2 |
Acromegaly, a pituitary special issue
|
Fleseriu, Maria |
|
2017 |
20 |
1 |
p. 2-3 |
artikel |
3 |
Acromegaly: clinical features at diagnosis
|
Vilar, Lucio |
|
2016 |
20 |
1 |
p. 22-32 |
artikel |
4 |
Biochemical investigations in diagnosis and follow up of acromegaly
|
Schilbach, Katharina |
|
2017 |
20 |
1 |
p. 33-45 |
artikel |
5 |
Cabergoline in acromegaly
|
Kuhn, Emmanuelle |
|
2016 |
20 |
1 |
p. 121-128 |
artikel |
6 |
Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
|
Pivonello, Rosario |
|
2017 |
20 |
1 |
p. 46-62 |
artikel |
7 |
Complications of acromegaly: thyroid and colon
|
Tirosh, Amit |
|
2016 |
20 |
1 |
p. 70-75 |
artikel |
8 |
David L. Kleinberg: in memoriam
|
|
|
2017 |
20 |
1 |
p. 1 |
artikel |
9 |
Epidemiology of acromegaly: review of population studies
|
Lavrentaki, Aikaterini |
|
2016 |
20 |
1 |
p. 4-9 |
artikel |
10 |
Management of aggressive growth hormone secreting pituitary adenomas
|
Donoho, Daniel A. |
|
2016 |
20 |
1 |
p. 169-178 |
artikel |
11 |
New medical therapies on the horizon: oral octreotide
|
Biermasz, Nienke R. |
|
2017 |
20 |
1 |
p. 149-153 |
artikel |
12 |
Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary
|
Syro, Luis V. |
|
2016 |
20 |
1 |
p. 84-92 |
artikel |
13 |
Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly
|
Tritos, Nicholas A. |
|
2016 |
20 |
1 |
p. 129-135 |
artikel |
14 |
Pregnancy and acromegaly
|
Muhammad, Ammar |
|
2016 |
20 |
1 |
p. 179-184 |
artikel |
15 |
Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas
|
Ben-Shlomo, Anat |
|
2016 |
20 |
1 |
p. 93-99 |
artikel |
16 |
Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance
|
Paragliola, Rosa Maria |
|
2016 |
20 |
1 |
p. 109-115 |
artikel |
17 |
Somatostatin receptor ligands in the treatment of acromegaly
|
Gadelha, Monica R. |
|
2017 |
20 |
1 |
p. 100-108 |
artikel |
18 |
The genetic background of acromegaly
|
Gadelha, Mônica R. |
|
2017 |
20 |
1 |
p. 10-21 |
artikel |
19 |
The role of combination medical therapy in the treatment of acromegaly
|
Lim, Dawn Shao Ting |
|
2016 |
20 |
1 |
p. 136-148 |
artikel |
20 |
The surgical treatment of acromegaly
|
Buchfelder, Michael |
|
2016 |
20 |
1 |
p. 76-83 |
artikel |
21 |
T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective
|
Potorac, Iulia |
|
2017 |
20 |
1 |
p. 116-120 |
artikel |
22 |
Update on quality of life in patients with acromegaly
|
Crespo, Iris |
|
2016 |
20 |
1 |
p. 185-188 |
artikel |
23 |
Updates in outcomes of stereotactic radiation therapy in acromegaly
|
Gheorghiu, Monica Livia |
|
2017 |
20 |
1 |
p. 154-168 |
artikel |